Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting tumor angiogenesis with gene therapy.

Q R Chen1, L Zhang, W Gasper

  • 1Department of Pathology, University of Maryland at Baltimore, Baltimore, Maryland 21201, USA.

Molecular Genetics and Metabolism
|October 11, 2001
PubMed
Summary

Cancer gene therapy targets tumor angiogenesis, with systemic delivery showing promise in preclinical models. Future clinical success hinges on developing safer, more effective gene therapy vectors for antiangiogenic treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antiangiogenic Gene Therapy in Cancer.

Current genomics·2018
Same author

Zinc Finger Nucleases: Tailor-made for Gene Therapy.

Drugs of the future·2013
Same author

Selective modification of HK peptides enhances siRNA silencing of tumor targets in vivo.

Cancer gene therapy·2011
Same author

Peptide-based Antifungal Therapies against Emerging Infections.

Drugs of the future·2010
Same author

Systemic delivery of HK Raf-1 siRNA polyplexes inhibits MDA-MB-435 xenografts.

Cancer gene therapy·2008
Same author

Branched co-polymers of histidine and lysine are efficient carriers of plasmids.

Nucleic acids research·2001

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Tumor angiogenesis, the formation of new blood vessels that feed tumors, is a key target for cancer gene therapy.
  • Gene therapy offers a promising approach to inhibit tumor angiogenesis, particularly when administered systemically due to vascular accessibility.

Purpose of the Study:

  • To review the current status of gene therapy targeting tumor angiogenesis.
  • To discuss future directions and challenges in developing antiangiogenic gene therapy.

Main Methods:

  • Review of preclinical studies on viral and nonviral gene-based therapies for antiangiogenic treatment.
  • Analysis of the principles and potential of gene therapy in targeting tumor vasculature.

Main Results:

Related Experiment Videos

  • Gene therapy targeting tumor angiogenesis has demonstrated proof of principle in preclinical models.
  • Systemic administration of gene therapy vectors is a feasible approach for targeting tumor vasculature.

Conclusions:

  • Antiangiogenic gene therapy holds significant potential for cancer treatment.
  • Further development of vectors with reduced toxicity and enhanced in vivo transfection efficiency is crucial for clinical application.